Strategies to increase nitric oxide signalling in cardiovascular disease

JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …

Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials

AS Antonopoulos, M Margaritis, R Lee… - Current …, 2012 - ingentaconnect.com
Ample evidence exists in support of the potent anti-inflammatory properties of statins. In cell
studies and animal models statins exert beneficial cardiovascular effects. By inhibiting …

Endothelial dysfunction due to eNOS uncoupling: Molecular mechanisms as potential therapeutic targets

A Janaszak-Jasiecka, A Płoska, JM Wierońska… - Cellular & molecular …, 2023 - Springer
Nitric oxide (NO) is one of the most important molecules released by endothelial cells, and
its antiatherogenic properties support cardiovascular homeostasis. Diminished NO …

Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases

SA Omar, AJ Webb, JO Lundberg… - Journal of internal …, 2016 - Wiley Online Library
Nitric oxide (NO) is generated endogenously by NO synthases to regulate a number of
physiological processes including cardiovascular and metabolic functions. A decrease in the …

Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease

J Goveia, P Stapor, P Carmeliet - EMBO molecular medicine, 2014 - embopress.org
The endothelium is the orchestral conductor of blood vessel function. Pathological blood
vessel formation (a process termed pathological angiogenesis) or the inability of endothelial …

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations

C Serban, A Sahebkar, S Ursoniu, DP Mikhailidis… - Scientific reports, 2015 - nature.com
The impact of statin therapy on plasma asymmetric dimethylarginine (ADMA) levels has not
been conclusively studied. Therefore the aim of the meta-analysis was to assess the effect of …

Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms

L Liberale, F Carbone, F Montecucco… - The international journal …, 2020 - Elsevier
Chronic inflammation enhances the detrimental role of dyslipidaemia during atherogenesis.
Statins are among the most effective anti-atherosclerotic medications, being able to impact …

Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) enzymes as an emerging therapeutic strategy to target angiogenesis and vasculogenic mimicry in …

JA Hulin, EA Gubareva, N Jarzebska… - Frontiers in …, 2020 - frontiersin.org
The small free radical gas nitric oxide (NO) plays a key role in various physiological and
pathological processes through enhancement of endothelial cell survival and proliferation …

MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic …

L Zhang, D Huang, Q Wang, D Shen, Y Wang… - … drugs and therapy, 2014 - Springer
Purpose Inflammation participates centrally in all stages of atherosclerosis (AS), which
begins with pro-inflammatory processes and inflammatory changes in the endothelium …

Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?

AA Zeki, JM Bratt, M Rabowsky, JA Last… - Translational …, 2010 - Elsevier
Airway remodeling in asthma contributes to airway hyperreactivity, loss of lung function, and
persistent symptoms. Current therapies do not adequately treat the structural airway …